Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-08-19Clinical Trial Update: A Randomized Clinical Evaluation of the BioFreedom™ Stent [NA]
This document provides a clinical trial update for a randomized evaluation of the BioFreedom stent, with the trial status currently unknown.
-
FDA approval · 2015-08-18FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter's Supplemental Application for Heparin Sodium in Sodium Chloride (Heparin Sodium), approving changes to an already-appro…
-
CLINICAL_TRIALS research · 2015-08-17Clinical Trial Update: High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery
Clinical trial update examining high-sensitivity Troponin T in acute myocardial infarction after cardiac valvular surgery; trial status is u…
-
FDA approval · 2015-08-13FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for metoprolol tartrate from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
Clinical trial update investigating myocardial silent infarctions and fibrosis in patients with familial hypercholesterolemia (heterozygous)…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling
This completed clinical trial evaluates circulating microRNA-126 as a biomarker for remodeling after myocardial infarction.
-
FDA approval · 2015-07-28FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, for a generic version of clopidogrel.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population [Phase 4]
Phase 4 trial comparing Promus Element (everolimus-eluting) and Resolute Integrity (zotarolimus-eluting) durable-polymer stents in an all-co…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: A Pilot Study of Transcoronary Myocardial Cooling [NA]
Pilot study of transcoronary myocardial cooling in patients with acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Observational Study of the Remodelling Process Following Myocardial Infarct
Observational study assessing the remodeling process following myocardial infarction. The study status is completed.
-
CLINICAL_TRIALS research · 2015-07-27Clinical Trial Update: Myocardial Deformation in Real-time 3D Ultrasound. Normal Values in Adults and Validation Against the Tagged MRI [NA]
Clinical trial update evaluating myocardial deformation with real-time 3D ultrasound, establishing normal values in adults and validating th…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: SHORTness of Breath In the Emergency Department (SHORTIE) [Phase 2, Phase 3]
A Phase 2/3 clinical trial named SHORTIE evaluating a treatment for acute myocardial infarction, heart failure, and pulmonary embolism has c…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Pericardic Adipose Pedicle Transposition Over the Myocardial Infarct (adiFLAP Trial) [Phase 1, Phase 2]
This document reports the completion of the adiFLAP trial evaluating pericardial adipose pedicle transposition over the myocardial infarct i…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Web-Enhanced Guideline Implementation for Post MI CBOC Patients [NA]
VA-sponsored clinical trial evaluating web-enhanced guideline implementation for patients after myocardial infarction; results were posted i…
-
CLINICAL_TRIALS research · 2015-07-22Clinical Trial Update: Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease [Phase 1, Phase 2]
Clinical trial update on autologous preconditioned bone marrow mesenchymal stem cells for ischemic heart disease, evaluated in Phase 1 and P…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Role of Adiponectin and Endothelial Progenitor Cells in Reperfusion Injury in Patients With Acute Myocardial Infarction
Completed clinical trial evaluating the role of adiponectin and endothelial progenitor cells in reperfusion injury after acute myocardial in…
-
CLINICAL_TRIALS withdrawal · 2015-07-21Clinical Trial Update: Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department
A clinical trial evaluating serial troponin and cardiac multimarkers at the point of care in the emergency department has been withdrawn.
-
FDA approval · 2015-07-16FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA lists a supplemental application for Plavix (clopidogrel) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-07-15FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC, updating the drug’s labeling as part of a …
-
EMA withdrawal · 2015-07-10EMA Withdrawn: Clopidogrel DURA (clopidogrel (as hydrochloride)) — Mylan dura GmbH
The EMA has withdrawn Clopidogrel DURA (clopidogrel hydrochloride) from the market for peripheral vascular diseases, stroke, and myocardial …
-
FDA approval · 2015-07-09FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental NDA for Tenormin (atenolol) submitted by Almatica Pharma LLC, authorizing a supplemental labeling/indication…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction andpREServed Lef venTricle Ejection Fraction (ARREST) [Phase 2]
Phase 2 ARREST trial assessed continuous rhythm monitoring in patients after acute myocardial infarction with preserved left ventricular eje…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Outcome After Coronary Artery Bypass Grafting
This clinical trial update discusses outcomes after coronary artery bypass grafting in patients with coronary artery disease and a history o…
-
CLINICAL_TRIALS withdrawal · 2015-07-03Clinical Trial Update: Inflammation in Type 2 Myocardial Infarction
This clinical trial investigating inflammation in Type 2 myocardial infarction has been withdrawn.
-
FDA approval · 2015-07-01FDA Approved: ATENOLOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Atenolol from Mylan Pharmaceuticals Inc., approving changes to the approved ANDA.